Literature DB >> 20546033

Molecular characterization of 11 novel mutations in patients with heterozygous and homozygous FV deficiency.

J A Cutler1, R Patel, S Rangarajan, R C Tait, M J Mitchell.   

Abstract

Coagulation factor V (FV) has an important role in the blood coagulation cascade, in both the pro- and anticoagulant pathways. FV deficiency is a rare bleeding disorder with variable phenotypic expression. We report a cohort of 10 patients with mild-severe FV deficiency in whom a total of 11 novel mutations were identified. Three patients were compound heterozygous for two mutations, whereas each of the remaining patients had a single heterozygous variant. FV levels did not correlate with either the type of mutation identified or the bleeding diathesis exhibited by the patients. Although considered to have an autosomal recessive mode of inheritance, patients with a single missense mutation may present with a significant bleeding history. The addition of a significant number of previously unidentified mutations to the public domain will contribute to the knowledge and understanding of the molecular pathology of this rare disorder.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20546033     DOI: 10.1111/j.1365-2516.2010.02330.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  3 in total

1.  Platelets and platelet-derived factor Va confer hemostatic competence in complete factor V deficiency.

Authors:  Beth A Bouchard; John Chapin; Kathleen E Brummel-Ziedins; Peter Durda; Nigel S Key; Paula B Tracy
Journal:  Blood       Date:  2015-04-20       Impact factor: 22.113

2.  Development of a microplate coagulation assay for Factor V in human plasma.

Authors:  Derek Tilley; Irina Levit; John A Samis
Journal:  Thromb J       Date:  2011-06-28

3.  Measurement of factor v activity in human plasma using a microplate coagulation assay.

Authors:  Derek Tilley; Irina Levit; John A Samis
Journal:  J Vis Exp       Date:  2012-09-09       Impact factor: 1.355

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.